job_id,protein,ligand,status,output,log,affinity_kcal_mol,time_seconds
EGFR_axitinib,EGFR,axitinib,SUCCESS,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/EGFR/axitinib_docked.pdbqt,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/EGFR/axitinib_smina.log,-8.4,43.5
EGFR_azd3759,EGFR,azd3759,SUCCESS,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/EGFR/azd3759_docked.pdbqt,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/EGFR/azd3759_smina.log,-9.2,114.3
EGFR_cediranib,EGFR,cediranib,SUCCESS,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/EGFR/cediranib_docked.pdbqt,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/EGFR/cediranib_smina.log,-8.2,158.8
EGFR_dabrafenib,EGFR,dabrafenib,SUCCESS,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/EGFR/dabrafenib_docked.pdbqt,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/EGFR/dabrafenib_smina.log,-9.7,197.4
EGFR_erlotinib,EGFR,erlotinib,SUCCESS,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/EGFR/erlotinib_docked.pdbqt,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/EGFR/erlotinib_smina.log,-7.6,151.3
EGFR_foretinib,EGFR,foretinib,SUCCESS,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/EGFR/foretinib_docked.pdbqt,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/EGFR/foretinib_smina.log,-10.2,394.6
EGFR_gefitinib,EGFR,gefitinib,SUCCESS,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/EGFR/gefitinib_docked.pdbqt,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/EGFR/gefitinib_smina.log,-8.5,109.8
EGFR_lapatinib,EGFR,lapatinib,SUCCESS,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/EGFR/lapatinib_docked.pdbqt,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/EGFR/lapatinib_smina.log,-9.2,243.1
EGFR_motesanib,EGFR,motesanib,SUCCESS,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/EGFR/motesanib_docked.pdbqt,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/EGFR/motesanib_smina.log,-9.0,63.0
EGFR_osimertinib,EGFR,osimertinib,SUCCESS,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/EGFR/osimertinib_docked.pdbqt,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/EGFR/osimertinib_smina.log,-9.0,194.5
EGFR_plx-4720,EGFR,plx-4720,SUCCESS,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/EGFR/plx-4720_docked.pdbqt,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/EGFR/plx-4720_smina.log,-8.8,89.1
EGFR_sapitinib,EGFR,sapitinib,SUCCESS,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/EGFR/sapitinib_docked.pdbqt,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/EGFR/sapitinib_smina.log,-8.6,157.1
EGFR_sb590885,EGFR,sb590885,SUCCESS,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/EGFR/sb590885_docked.pdbqt,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/EGFR/sb590885_smina.log,-10.5,130.2
EGFR_sorafenib,EGFR,sorafenib,SUCCESS,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/EGFR/sorafenib_docked.pdbqt,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/EGFR/sorafenib_smina.log,-9.3,121.5
BRAF_afatinib,BRAF,afatinib,SUCCESS,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/BRAF/afatinib_docked.pdbqt,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/BRAF/afatinib_smina.log,-8.4,228.6
BRAF_axitinib,BRAF,axitinib,SUCCESS,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/BRAF/axitinib_docked.pdbqt,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/BRAF/axitinib_smina.log,-8.4,98.5
BRAF_azd3759,BRAF,azd3759,SUCCESS,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/BRAF/azd3759_docked.pdbqt,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/BRAF/azd3759_smina.log,-9.6,168.2
BRAF_cediranib,BRAF,cediranib,SUCCESS,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/BRAF/cediranib_docked.pdbqt,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/BRAF/cediranib_smina.log,-8.4,227.7
BRAF_dabrafenib,BRAF,dabrafenib,SUCCESS,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/BRAF/dabrafenib_docked.pdbqt,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/BRAF/dabrafenib_smina.log,-9.5,199.3
BRAF_erlotinib,BRAF,erlotinib,SUCCESS,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/BRAF/erlotinib_docked.pdbqt,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/BRAF/erlotinib_smina.log,-7.1,171.7
BRAF_foretinib,BRAF,foretinib,SUCCESS,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/BRAF/foretinib_docked.pdbqt,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/BRAF/foretinib_smina.log,-9.3,589.2
BRAF_gefitinib,BRAF,gefitinib,SUCCESS,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/BRAF/gefitinib_docked.pdbqt,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/BRAF/gefitinib_smina.log,-8.6,210.7
BRAF_lapatinib,BRAF,lapatinib,SUCCESS,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/BRAF/lapatinib_docked.pdbqt,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/BRAF/lapatinib_smina.log,-9.6,416.8
BRAF_motesanib,BRAF,motesanib,SUCCESS,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/BRAF/motesanib_docked.pdbqt,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/BRAF/motesanib_smina.log,-8.2,135.3
BRAF_osimertinib,BRAF,osimertinib,SUCCESS,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/BRAF/osimertinib_docked.pdbqt,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/BRAF/osimertinib_smina.log,-9.0,340.9
BRAF_plx-4720,BRAF,plx-4720,SUCCESS,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/BRAF/plx-4720_docked.pdbqt,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/BRAF/plx-4720_smina.log,-7.4,137.0
BRAF_sapitinib,BRAF,sapitinib,SUCCESS,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/BRAF/sapitinib_docked.pdbqt,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/BRAF/sapitinib_smina.log,-8.3,225.7
BRAF_sb590885,BRAF,sb590885,SUCCESS,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/BRAF/sb590885_docked.pdbqt,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/BRAF/sb590885_smina.log,-8.4,184.9
BRAF_sorafenib,BRAF,sorafenib,SUCCESS,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/BRAF/sorafenib_docked.pdbqt,/Users/favourigwezeke/Personal_System/Research/Dr. Charles Nnadi/CASPID/DATA/DOCKING/SMINA_RESULTS/BRAF/sorafenib_smina.log,-9.8,174.8
